Luminex, Merck to develop companion Dx for Alzheimer's drug

03/14/2013 | GenomeWeb Daily News (free registration) · Fox Business

Luminex and Merck & Co. have entered a partnership to develop a companion test for the latter's MK-8931, an investigational drug for Alzheimer's disease. The test will be used to screen patients for a clinical trial of MK-8931. The assay will assess levels of two potential disease biomarkers in cerebrospinal fluid samples from patients who demonstrate mild cognitive impairment.

View Full Article in:

GenomeWeb Daily News (free registration) · Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA